Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2021 Gastrointestinal Cancers Symposium
2020 San Antonio Breast Cancer Symposium
2020 ASH Annual Meeting & Exposition
ESMO Immuno-Oncology Virtual Congress 2020
ESMO Asia Virtual Congress 2020
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Roundtable:
Lymphoma/Myeloma
Roundtable:
Lung Cancer
Podcasts
CME
Methotrexate–Induced Kidney Injury
Advertisement
David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease
First International Summit on Interventional Pharmacoeconomics
Advertisement
Related Videos
Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19
CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country
Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)
Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors
Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics
Advertisement
Advertisement
Jan
26
Today In Oncology
New Study Finds Suspicious Lesions on Breast MRI in Neoadjuvant Setting Are Unlikely to Be Malignant
IMpower133 Update Atezolizumab Plus Carboplatin/Etoposide for Extensive-Stage Small Cell Lung Cancer
Multiancestry Meta-analysis of Prostate Cancer Genetics
Final Overall Survival Results of the IDEA Collaboration 3 vs 6 Months of Adjuvant Chemotherapy for Stage III Colon Cancer
Integrated Palliative and Oncology Care for Patients Receiving Treatment for Acute Myeloid Leukemia
View More
Advertisement